Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes

Open access
Voss, William N., Hou, Yixuan J., Johnson, Nicole V., Delidakis, George, Kim, Jin Eyun, Javanmardi, Kamyab, Horton, Andrew P., Bartzoka, Foteini, Paresi, Chelsea J., Tanno, Yuri, Chou, Chia-Wei, Abbasi, Shawn A., Pickens, Whitney, George, Katia, Boutz, Daniel R., Towers, Dalton M., McDaniel, Jonathan R., Billick, Daniel, Goike, Jule, Rowe, Lori, Batra, Dhwani, Pohl, Jan, Lee, Justin, Gangappa, Shivaprakash, Sambhara, Suryaprakash, Gadush, Michelle, Wang, Nianshuang, Person, Maria D., Iverson, Brent L., Gollihar, Jimmy D., Dye, John M., Herbert, Andrew S., Finkelstein, Ilya J., Baric, Ralph S., McLellan, Jason S., Georgiou, George, Lavinder, Jason J., Ippolito, Gregory C. · 2021 · Science

Published version of a preprint

Abstract

A public anti-COVID antibody repertoire: Most analyses of the antibody responses induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have focused on antibodies cloned from memory B cells. This approach has led researchers to conclude that neutralizing antibodies (nAbs) primarily target the receptor-binding domain (RBD) of the virus's spike protein. Voss et al. took a different approach, using proteomic deconvolution of the serum immunoglobulin G antibody repertoire from four COVID-19 convalescent patients. They found that the nAb response was largely directed against epitopes such as the N-terminal domain (NTD), which lie outside the RBD. Several of these nAbs were shared among donors and targeted an NTD epitope that is frequently mutated by variants of concern. Science , abg5268, this issue p. 1108

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.abg5268

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Research works printed but not linked: 1

  1. 10.1016/j.cell.2020.02.058 · doi:10.1016/j.cell.2020.02.058 · Paper page

Cited by

See all 260

Metadata

Authors
Voss, W. N., Hou, Y. J., Johnson, N. V., Delidakis, G., Kim, J. E., Javanmardi, K., Horton, A. P., Bartzoka, F., Paresi, C. J., Tanno, Y., Chou, C.-W., Abbasi, S. A., Pickens, W., George, K., Boutz, D. R., Towers, D. M., McDaniel, J. R., Billick, D., Goike, J., Rowe, L., Batra, D., Pohl, J., Lee, J., Gangappa, S., Sambhara, S., Gadush, M., Wang, N., Person, M. D., Iverson, B. L., Gollihar, J. D., Dye, J. M., Herbert, A. S., Finkelstein, I. J., Baric, R. S., McLellan, J. S., Georgiou, G., Lavinder, J. J., & Ippolito, G. C.
Venue
Science
Published
2021-06-04
Volume
372
Issue
6546
Pages
1108-1112
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W3158062106
Cited by
260
References
70
FWCI
16.95
Type
journal article
Language
en
Open access
hybrid
Funders
  • National Cancer Institute (U54-CA260543)
  • National Institute of Allergy and Infectious Diseases (R01-AI127521, 75N93019C00050, NIH NCI COVID-19)
  • University of California, San Francisco (NIH P41-GM103311)
  • United States Army Medical Research Institute of Infectious Diseases (14066041)
  • College of Natural Sciences, University of Texas at Austin (RR160023)
  • Welch Foundation (F-0003-19620604)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes. https://app.cochat.ai/papers/10.1126/science.abg5268
The paper
Voss, W. N., Hou, Y. J., Johnson, N. V., Delidakis, G., Kim, J. E., Javanmardi, K., Horton, A. P., Bartzoka, F., Paresi, C. J., Tanno, Y., Chou, C.-W., Abbasi, S. A., Pickens, W., George, K., Boutz, D. R., Towers, D. M., McDaniel, J. R., Billick, D., Goike, J., . . . Ippolito, G. C. (2021). Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes. Science. https://doi.org/10.1126/science.abg5268

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.